Bim, p53-up-regulated modulator of apoptosis (PUMA) and NOXA have been recently reported to play an important role in chemotherapy and targeted therapy induced apoptosis in breast cancer [6], leukemia [7], myeloma [8] and NSCLC [9] cells. Here, BCL2L11 is linked to breast carcinoma.